Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From MD Biosciences
Two companies and two hospitals are marketing Zika virus diagnostics without FDA go-ahead, the agency said in letters that asked the organizations for data supporting their assays.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Contract Research, Toxicology Testing-CRO
- Research, Analytical Equipment & Supplies
- Drug Discovery Tools